These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22474372)

  • 1. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.
    Wang F; Marshall CB; Yamamoto K; Li GY; Gasmi-Seabrook GM; Okada H; Mak TW; Ikura M
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6078-83. PubMed ID: 22474372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interplay between promoter recognition and CBP/p300 coactivator recruitment by FOXO3a.
    Wang F; Marshall CB; Li GY; Yamamoto K; Mak TW; Ikura M
    ACS Chem Biol; 2009 Dec; 4(12):1017-27. PubMed ID: 19821614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
    Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and mechanistic insights into the interaction of the circadian transcription factor BMAL1 with the KIX domain of the CREB-binding protein.
    Garg A; Orru R; Ye W; Distler U; Chojnacki JE; Köhn M; Tenzer S; Sönnichsen C; Wolf E
    J Biol Chem; 2019 Nov; 294(45):16604-16619. PubMed ID: 31515273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain.
    Goto NK; Zor T; Martinez-Yamout M; Dyson HJ; Wright PE
    J Biol Chem; 2002 Nov; 277(45):43168-74. PubMed ID: 12205094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.
    Cook PR; Polakowski N; Lemasson I
    J Mol Biol; 2011 Jun; 409(3):384-98. PubMed ID: 21497608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300.
    Ramírez JA; Nyborg JK
    J Mol Biol; 2007 Sep; 372(4):958-969. PubMed ID: 17707401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for cooperative transcription factor binding to the CBP coactivator.
    De Guzman RN; Goto NK; Dyson HJ; Wright PE
    J Mol Biol; 2006 Feb; 355(5):1005-13. PubMed ID: 16253272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb.
    Joy ST; Henley MJ; De Salle SN; Beyersdorf MS; Vock IW; Huldin AJL; Mapp AK
    J Am Chem Soc; 2021 Sep; 143(37):15056-15062. PubMed ID: 34491719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
    Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
    Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational control of the binding of the transactivation domain of the MLL protein and c-Myb to the KIX domain of CREB.
    Korkmaz EN; Nussinov R; Haliloğlu T
    PLoS Comput Biol; 2012; 8(3):e1002420. PubMed ID: 22438798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function.
    So CW; Cleary ML
    Mol Cell Biol; 2002 Sep; 22(18):6542-52. PubMed ID: 12192052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leu628 of the KIX domain of CBP is a key residue for the interaction with the MLL transactivation domain.
    Arai M; Dyson HJ; Wright PE
    FEBS Lett; 2010 Nov; 584(22):4500-4. PubMed ID: 20969867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and structural characterization of an intramolecular interaction in FOXO3a and its binding with p53.
    Wang F; Marshall CB; Yamamoto K; Li GY; Plevin MJ; You H; Mak TW; Ikura M
    J Mol Biol; 2008 Dec; 384(3):590-603. PubMed ID: 18824006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
    Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
    J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Basis for the Mechanism of Constitutive CBP/p300 Coactivator Recruitment by CRTC1-MAML2 and Its Implications in cAMP Signaling.
    Clark MD; Kumar GS; Marcum R; Luo Q; Zhang Y; Radhakrishnan I
    Biochemistry; 2015 Sep; 54(35):5439-46. PubMed ID: 26274502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
    Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic interaction between mutations in c-Myb and the KIX domains of CBP and p300 affects multiple blood cell lineages and influences both gene activation and repression.
    Kasper LH; Fukuyama T; Lerach S; Chang Y; Xu W; Wu S; Boyd KL; Brindle PK
    PLoS One; 2013; 8(12):e82684. PubMed ID: 24340053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
    Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
    Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human T-cell leukemia virus type 1 tax protein confers CBP/p300 recruitment and transcriptional activation properties to phosphorylated CREB.
    Geiger TR; Sharma N; Kim YM; Nyborg JK
    Mol Cell Biol; 2008 Feb; 28(4):1383-92. PubMed ID: 18070920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.